31st International Precision Med TRI-CON
일정 : 2024년 3월 26-28일
개최: USA
해당 컨퍼런스는 종료되었습니다.
Choose your language
Traditional Chinese
Simplified Chinese
Japanese
English_

Catalog Download
Catalog

TRI-CON 2024 : 진단·정밀의료에서의 혁신과 협업을 30년 이상 추진

Precision Med TRI-CON은 과거 30년간 진단·정밀의료 커뮤니티에 중요한 국제 회의 장소로서 기능해 왔습니다. 세계 각국으로부터 수천 명의 오피니언 리더가 모여 최신 연구 및 기술, 혁신, 비즈니스 모델에 대해 논의합니다. 구체적으로는 감염증용 정밀의료·POC 검사·분자진단의 도입 및 감염증용 재택 진단·POC 검사·분자진단에 관한 혁신과 시장 접근 전략, 정밀 종양학용 액체생검과 첨단 진단(다중암의 조기 발견 및 미세잔존질환 검사 포함) 등입니다. 2024년 컨퍼런스에서는 발전중인 정밀의료에서 시퀀싱의 고속화·저가격화 및 AI와 디지털 툴, 공간 생물학과 싱글 셀 멀티오믹스 등의 새로운 의의에 대해서도 다룹니다. 대면 네트워킹 및 TRI-CON으로부터 기대하는 비전과 생각을 자극하는 기조 강연에 참여할 수 있는 화창한 샌디에고에서 만납시다!



2024년 메인 연사


J. Craig Venter

FIRESIDE CHAT: Artificial Intelligence Innovation for Precision Medicine
FIRESIDE CHAT : 정밀의료용 인공지능의 혁신

Eric Topol, MD, Director, Scripps Research Translational Institute; Executive Vice President and Professor, Scripps Research

Interviewed by: Mara G. Aspinall, Partner, Illumina Ventures; Professor of Practice, Arizona State University


Kari Stefansson

Kari Stefansson
CEO
deCODE genetics

Mara Aspinall

Mara Aspinall
Partner
Illumina Ventures

Anthony Sireci

Anthony Sireci
SVP, Diagnostics Development, Loxo Oncology
Eli Lilly

Atul Butte

Atul Butte
Chief Data Scientist
University of California Health

Hoi-Ying Elsie Yu
Laboratory Director, Point-of-Care Testing
Geisinger Health

Esther Babady

Esther Babady
Section Head, Clinical Microbiology
Memorial Sloan Kettering Cancer Center

Jeffrey Venstrom

Jeffrey Venstrom
CMO
GRAIL

Razelle Kurzrock

Razelle Kurzrock
CMO
Worldwide Innovative Network for Personalized Cancer Therapy

Jonathan Carlson

Jonathan Carlson
Managing Director
Microsoft Health Futures

Sonya Makhni

Sonya Makhni
Medical Director
Mayo Clinic Platform

Ezra Cohen

Ezra Cohen
CMO, Oncology
Tempus Labs

Howard Scher

Howard Scher
Head, Biomarker Development
Memorial Sloan Kettering Cancer Center

Jean-Francois Martini

Jean-Francois Martini
Diagnostics Lead, Oncology
Pfizer

Lourdes Barrera

Lourdes Barrera
Executive Director, Precision Medicine
Merck

Christopher Hartshorn

Christopher Hartshorn
Chief, Digital & Mobile Technologies
NCATS

Jai Pandey

Jai Pandey
Head, Global Device Regulatory IVD/CDx
Sanofi

George Vacek

George Vacek
Global Head, Genomics Alliances
NVIDIA

Larissa May

Larissa May
Director, Emergency Medicine Innovation
UC Davis Health

Peter Bach

Peter Bach
CMO
Delfi Diagnostics

Anne Beaubrun

Anne Beaubrun
VP, Global Health Economics & Outcomes
Cepheid

Yuan Luo

Yuan Luo
Chief AI Officer, Northwestern Univ.
Feinberg School of Medicine

John Mattison

John Mattison
Chief Medical Information Officer
Arsenal Capital Partners

Jennifer Quigley

Jennifer Quigley
Sr. Director, Precision Diagnostics
Novartis

Scott Penberthy

Scott Penberthy
Managing Director, Applied AI
Google Cloud

Sudhir Srivastava

Sudhir Srivastava
Chief, Cancer Biomarkers Research
NCI

Edward Abrahams

Edward Abrahams
President
Personalized Medicine Coalition

Jonathan Beer

Jonathan Beer
Sr. Director, Diagnostic Science
Bristol Myers Squibb

Jim Almas

Jim Almas
VP, Clinical Effectiveness
LabCorp

Stacey DaCosta Byfield

Stacey DaCosta Byfield
VP, Genomic Health Economics and Outcomes
Optum Labs

Larry Kessler

Larry Kessler
Co-Chair
MCED Consortium

Noah Zimmerman

Noah Zimmerman
VP, Translational Science
Tempus

Mark Gardner

Mark Gardner
SVP, Molecular Genomics
Quest Diagnostics

Lesley Northrop

Lesley Northrop
Chief Diagnostic Officer
Everly Health

Charles Chiu

Charles Chiu
Director, Clinical Microbiology Laboratory
UCSF

Christopher Conn

Christopher Conn
Director, Diagnostics Strategy
Amgen